INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
92.23 USD
-4.24 (-4.4%)
92.23 USD
0 (0%)
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While INSP has a great health rating, its profitability is only average at the moment. INSP has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- INSP had positive earnings in the past year.
- In the past year INSP had a positive cash flow from operations.
- INSP had negative earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
- INSP's Return On Assets of 5.52% is amongst the best of the industry. INSP outperforms 82.16% of its industry peers.
- The Return On Equity of INSP (6.69%) is better than 81.08% of its industry peers.
- INSP's Return On Invested Capital of 4.82% is fine compared to the rest of the industry. INSP outperforms 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- INSP's Profit Margin of 5.05% is fine compared to the rest of the industry. INSP outperforms 77.30% of its industry peers.
- INSP has a Operating Margin of 4.16%. This is in the better half of the industry: INSP outperforms 68.65% of its industry peers.
- Looking at the Gross Margin, with a value of 84.92%, INSP belongs to the top of the industry, outperforming 94.05% of the companies in the same industry.
- INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
- The number of shares outstanding for INSP has been increased compared to 1 year ago.
- Compared to 5 years ago, INSP has more shares outstanding
- There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 13.37 indicates that INSP is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 13.37, INSP belongs to the top of the industry, outperforming 91.35% of the companies in the same industry.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.37 |
ROIC/WACC0.48
WACC10%
2.3 Liquidity
- INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- INSP has a Current ratio of 5.29. This is amongst the best in the industry. INSP outperforms 81.08% of its industry peers.
- INSP has a Quick Ratio of 4.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 4.01, INSP is doing good in the industry, outperforming 76.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 90.65% over the past year.
- The Revenue has grown by 16.81% in the past year. This is quite good.
- Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 57.78% on average per year.
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
- The Earnings Per Share is expected to grow by 18.80% on average over the next years. This is quite good.
- INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.14% yearly.
EPS Next Y-38.85%
EPS Next 2Y1.25%
EPS Next 3Y15.12%
EPS Next 5Y18.8%
Revenue Next Year13.2%
Revenue Next 2Y12.21%
Revenue Next 3Y12.2%
Revenue Next 5Y11.14%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 45.21, the valuation of INSP can be described as expensive.
- Based on the Price/Earnings ratio, INSP is valued a bit cheaper than 69.73% of the companies in the same industry.
- INSP is valuated expensively when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 52.00, the valuation of INSP can be described as expensive.
- INSP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 68.65% of the companies in the same industry.
- INSP is valuated expensively when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.21 | ||
| Fwd PE | 52 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 67.03% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 81.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.12 | ||
| EV/EBITDA | 46.03 |
4.3 Compensation for Growth
- INSP's earnings are expected to grow with 15.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.25%
EPS Next 3Y15.12%
5. Dividend
5.1 Amount
- No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
92.23
-4.24 (-4.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12 2026-01-12/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners111.59%
Inst Owner Change0.99%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap2.68B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target142.79 (54.82%)
Short Float %12.07%
Short Ratio2.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)12.65%
PT rev (3m)3.29%
EPS NQ rev (1m)-1.63%
EPS NQ rev (3m)-0.13%
EPS NY rev (1m)13.12%
EPS NY rev (3m)110.93%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.91%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.21 | ||
| Fwd PE | 52 | ||
| P/S | 3.04 | ||
| P/FCF | 27.12 | ||
| P/OCF | 20.05 | ||
| P/B | 4.02 | ||
| P/tB | 4.02 | ||
| EV/EBITDA | 46.03 |
EPS(TTM)2.04
EY2.21%
EPS(NY)1.77
Fwd EY1.92%
FCF(TTM)3.4
FCFY3.69%
OCF(TTM)4.6
OCFY4.99%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 13.37 |
F-Score8
WACC10%
ROIC/WACC0.48
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-38.85%
EPS Next 2Y1.25%
EPS Next 3Y15.12%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.2%
Revenue Next 2Y12.21%
Revenue Next 3Y12.2%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.93%
EBIT Next 3Y123.99%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 45.21 and the Price/Book (PB) ratio is 4.02.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.